In order to assess the effect of varying glucose concentrations on plasma lipids, we first compared the hormonal response of nine non-diabetic patients during dialysis with a high (200 mg/dl) and a low (100 mg/dl) glucose bath. Insulin and growth hormone production increased (p < 0.05) only with the high glucose bath, and no hemodynamic differences were noted during either dialyses. We then compared lipid profiles of 18 patients for 6 months, changing the glucose dialysate concentrations in each patient after three months. We found that all patients had hypertriglyceridemia, mild hypercholesterolemia, low HDL, normal LDL, and high VLDL cholesterol. We therefore conclude that episodic hyperinsulinemia and episodic excessive growth hormone secretion do not contribute significantly to the lipid abnormalities of the dialysis patients.
SwamyA.P., CesteroR.U.M., CampbellR.G., FreemanR.B.Long-term effect of dialysate glucose on the lipid levels of maintenance hemodialysis patients.Trans Am Soc Artif Intern Organs1976; 22: 54–8.
2.
BiermanE.L.Abnormalities of carbohydrate and lipid metabolism in uremia.Arch Intern Med1970; 126: 790–2.
RamirezG., BercawB.L., ButcherD.E., MathisH.L., BrueggemeyerC., NewtonJ.L.The role of glucose in hemodialysis: the effects of glucose free dialysate.Am J Kidney Dis1986; 7: 413–20.
5.
HenrichW.L., WoodardT.D., BlachleJ.D., Gomez-SanchezC.C., PettingerW., CroninR.E.Role of osmolality in blood pressure stability after dialysis.Kidney Int1980; 18: 280–488.
6.
HenrichW.L., WoodardT.D., McPhaulJ.J.The chronic efficiency and safety of high sodium dialysate.Double crossover study. Am J Kidney Dis1982; 2: 349–53.
7.
KjellstrandC., RosaA., ShidemanJ.Hypotension during hemodialysis, osmolality is an important pathogenic factor.Trans Am Soc Artif Intern Organs1980; 3: 11–9.
8.
GlickS.M., RothJ., YalowR.S., BersonS.A.Immunoassay of human growth hormone in plasma.Nature1963; 199: 784–7.
9.
YalowR.S., BersonS.A.Immunoassay of endogenous plasma insulin in man.Recent Prog Horm Res1972; 28: 527–90.
10.
NolanG.E., SmithJ.B., ChavreV.J., JubizW.Spurious overestimation of plasma cortisol in patients with chronic renal failure.J Clin Endocrinol Metab1981; 52: 1242–5.
11.
CobbS.A., SaundersJ.L.Enzymatic determinations of cholesterol in serum lipoproteins.
12.
BagdadeJ.D., PorteD., BiermanE.L.Hypertriglyceridemia.A metabolic consequence of chronic renal failure. N Engl J Med1968; 279: 131–5.
TsaltasT.T., FriedmanE.A.Plasma lipid studies of uremic patients during hemodialysis.Am J Clin Nutr1968; 21: 430–53.
15.
BrunzellJ.D., AlbersJ.J., HaasL.B., GoldbergA.P., AgadaL., SherrardD.J.Prevalence of serum lipid abnormalities in chronic hemodialysis.Metabolism1977; 26: 903–10.
16.
DruekeT., LacourB., RoulletJ.B., Funck-BrentanoJ.L.Recent advances in factors that alter lipid metabolism in chronic renal failure.Kidney Int (Suppl)1983; 16: s134–s138.
BagdadeJ.D., AlbertsJ.J.Plasma high-density lipoprotein concentration in chronic hemodialysis and renal transplant patients.N Engl J Med1977; 296: 1436–9.
19.
TatamiR., MabuchiH., WedaK.Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.Circulation1981; 64: 1174–84.
20.
DombeckD.H., LinholmD.D., ViciraJ.A.Lipid metabolism in uremia and the effects of dialysate glucose and oral androgen therapy.Trans Am Soc Artif Intern Organs1973; 19: 150–3.
21.
WathenR.L., KeshaviachP., HommeyerB.A., CadwellK., ComtyC.M.The metabolic effects of hemodialysis with and without glucose in dialysate.Am J Clin Nutr1978; 31: 1870–5.
22.
RamirezG., O'NeilW.M., BloomerH.A., JubizW.Abnormalities in the regulation of growth hormone in chronic renal failure.Arhc Intern Med1978; 138: 267–71.
23.
RapaportJ., AviramJ., ChaimovitzC., BrookJ.G.Defective high-density lipoprotein composition in patients on chronic hemodialysis.N Engl J Med1978; 299: 1326–9.
24.
ChanM.K., VargheseZ., MoorhedJ.F.Lipid abnormalities in uremia, dialysis and transplantation.Kidney Int19: 625–37.
25.
CoxR.A., HoppelC.L.Carnitine and trimethylaminobutyrate synthesis in rat tissues.Biochem J1974; 142: 699–701.
26.
BazzatoG., MezzinaC., CimanM., GuarnieriG.Myasthenia-like syndrome associated with carnitine in patients on long term hemodialysis.Lancet1979; 1: 1041–2.
